» Articles » PMID: 34534487

Association of Enteropathogen Detection with Diarrhoea by Age and High Versus Low Child Mortality Settings: a Systematic Review and Meta-analysis

Abstract

Background: The odds ratio (OR) comparing pathogen presence in diarrhoeal cases versus asymptomatic controls is a measure for diarrhoeal disease cause that has been integrated into burden of disease estimates across diverse populations. This study aimed to estimate the OR describing the association between pathogen detection in stool and diarrhoea for 15 common enteropathogens by age group and child mortality setting.

Methods: We did a systematic review to identify case-control and cohort studies published from Jan 1, 1990, to July 9, 2019, which examined at least one enteropathogen of interest and the outcome diarrhoea. The analytical dataset included data extracted from published articles and supplemented with data from the Global Enteric Multicenter Study and the Malnutrition and Enteric Disease study. Random effects meta-analysis models were fit for each enteropathogen, stratified by age group and child mortality level, and adjusted for pathogen detection method and study design to produce summary ORs describing the association between pathogen detection in stool and diarrhoea.

Findings: 1964 records were screened and 130 studies (over 88 079 cases or diarrhoea samples and 135 755 controls or non-diarrhoea samples) were available for analysis. Heterogeneity (I) in unadjusted models was substantial, ranging from 27·6% to 86·6% across pathogens. In stratified and adjusted models, summary ORs varied by age group and setting, ranging from 0·4 (95% CI 0·2-0·6) for Giardia lamblia to 54·1 (95% CI 7·4-393·5) for Vibrio cholerae.

Interpretation: Incorporating effect estimates from diverse data sources into diarrhoeal disease cause and burden of disease models is needed to produce more representative estimates.

Funding: WHO, Bill & Melinda Gates Foundation, and National Institutes of Health.

Citing Articles

The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.

Baqar S, Bonavia A, Louis Bourgeois A, Campo J, Clifford A, Hanevik K Vaccine. 2023; 42(7):1445-1453.

PMID: 38036392 PMC: 10953702. DOI: 10.1016/j.vaccine.2023.11.045.


Why are so many enteric pathogen infections asymptomatic? Pathogen and gut microbiome characteristics associated with diarrhea symptoms and carriage of diarrheagenic in northern Ecuador.

Jesser K, Trueba G, Konstantinidis K, Levy K Gut Microbes. 2023; 15(2):2281010.

PMID: 37992406 PMC: 10730187. DOI: 10.1080/19490976.2023.2281010.


Epidemiology and Risk Factors of Norovirus Infections Among Diarrhea Patients Admitted to Tertiary Care Hospitals in Bangladesh.

Satter S, Abdullah Z, Fariha F, Karim Y, Rahman M, Balachandran N J Infect Dis. 2023; 228(7):818-828.

PMID: 37503737 PMC: 10547458. DOI: 10.1093/infdis/jiad274.


Long-term impacts of an urban sanitation intervention on enteric pathogens in children in Maputo city, Mozambique: study protocol for a cross-sectional follow-up to the Maputo Sanitation (MapSan) trial 5 years postintervention.

Holcomb D, Monteiro V, Capone D, Antonio V, Chiluvane M, Cumbane V BMJ Open. 2023; 13(6):e067941.

PMID: 37290945 PMC: 10254709. DOI: 10.1136/bmjopen-2022-067941.


Prevalence of diarrheagenic Escherichia coli and impact on child health in Cap-Haitien, Haiti.

Diaz J, Iannotti L, Dulience S, Vie S, Jiang X, Grigura V PLOS Glob Public Health. 2023; 3(5):e0001863.

PMID: 37145992 PMC: 10162540. DOI: 10.1371/journal.pgph.0001863.


References
1.
. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018; 18(11):1211-1228. PMC: 6202444. DOI: 10.1016/S1473-3099(18)30362-1. View

2.
Blackwelder W, Biswas K, Wu Y, Kotloff K, Farag T, Nasrin D . Statistical methods in the Global Enteric Multicenter Study (GEMS). Clin Infect Dis. 2012; 55 Suppl 4:S246-53. PMC: 3502316. DOI: 10.1093/cid/cis788. View

3.
Havelaar A, Swart A . Impact of waning acquired immunity and asymptomatic infections on case-control studies for enteric pathogens. Epidemics. 2016; 17:56-63. DOI: 10.1016/j.epidem.2016.11.004. View

4.
Prudden H, Hasso-Agopsowicz M, Black R, Troeger C, Reiner R, Breiman R . Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28-29th November 2018. Vaccine. 2020; 38(31):4792-4800. PMC: 7306158. DOI: 10.1016/j.vaccine.2020.01.054. View

5.
Lopman B, Hall A . Incomplete use of global data for aetiological attribution of diarrhoeal disease in the Global Burden of Disease study. Lancet Infect Dis. 2019; 19(2):128. DOI: 10.1016/S1473-3099(18)30798-9. View